Literature DB >> 1450410

T-cell acute lymphoblastic leukemia--the associated gene SCL/tal codes for a 42-Kd nuclear phosphoprotein.

A N Goldfarb1, S Goueli, D Mickelson, J M Greenberg.   

Abstract

SCL/tal is a putative oncogene originally identified through its involvement in the translocation t(1;14)(p32;q11) present in the leukemic cell line DU.528. Subsequent studies have shown an upstream deletion activating expression of SCL/tal to be one of the most common genetic lesions in T-cell acute lymphoblastic leukemia (T-ALL). The cDNA sequence of SCL/tal encodes a basic helix-loop-helix (bHLH) protein with regions of marked homology to lyl-1 and tal-2, two other bHLH proteins involved in T-ALL chromosomal translocations. The bHLH motif suggests that the SCL/tal product localizes to the nucleus, binds to specific DNA sequences, and regulates transcription of a specific array of target genes. Our studies directly identify the SCL/tal product as a 42-Kd phosphoprotein that efficiently localizes to the nucleus. Deletion mutagenesis has allowed identification of a region critical for nuclear localization, a region that corresponds to the DNA-binding basic domain within the bHLH motif. Because this domain is shared by lyl-1 and tal-2, these latter putative T-cell oncoproteins probably use a nuclear localization mechanism identical to that of SCL/tal.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1450410

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha.

Authors:  M A Kelliher; D C Seldin; P Leder
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

2.  Mitogen-activated protein kinase mediates erythropoietin-induced phosphorylation of the TAL1/SCL transcription factor in murine proerythroblasts.

Authors:  T Tang; K S Prasad; M J Koury; S J Brandt
Journal:  Biochem J       Date:  1999-11-01       Impact factor: 3.857

3.  Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice.

Authors:  D S Chervinsky; X F Zhao; D H Lam; M Ellsworth; K W Gross; P D Aplan
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

4.  Inhibition of all-trans retinoic acid-induced granulocytic differentiation of WEHI-3B D+ cells by forced expression of SCL (TAL1) and GATA-1.

Authors:  Kimiko Ishiguro; Anna M Rice; Kevin P Rice; Alan C Sartorelli
Journal:  Leuk Res       Date:  2009-02-20       Impact factor: 3.156

5.  The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells.

Authors:  V E Valge-Archer; H Osada; A J Warren; A Forster; J Li; R Baer; T H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

6.  Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion.

Authors:  K Leroy-Viard; M A Vinit; N Lecointe; H Jouault; U Hibner; P H Roméo; D Mathieu-Mahul
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.